FR1545224A - Process for preparing sebacic acid - Google Patents

Process for preparing sebacic acid

Info

Publication number
FR1545224A
FR1545224A FR129355A FR129355A FR1545224A FR 1545224 A FR1545224 A FR 1545224A FR 129355 A FR129355 A FR 129355A FR 129355 A FR129355 A FR 129355A FR 1545224 A FR1545224 A FR 1545224A
Authority
FR
France
Prior art keywords
sebacic acid
preparing sebacic
preparing
acid
sebacic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR129355A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5260266A external-priority patent/GB1196594A/en
Application filed by JR Geigy AG filed Critical JR Geigy AG
Priority to FR129355A priority Critical patent/FR1545224A/en
Application granted granted Critical
Publication of FR1545224A publication Critical patent/FR1545224A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/20—Sebacic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR129355A 1966-12-21 1967-11-23 Process for preparing sebacic acid Expired FR1545224A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR129355A FR1545224A (en) 1966-12-21 1967-11-23 Process for preparing sebacic acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5260266A GB1196594A (en) 1966-12-21 1966-12-21 Improvements in and relating to the production of Sebacic Acid
FR129355A FR1545224A (en) 1966-12-21 1967-11-23 Process for preparing sebacic acid

Publications (1)

Publication Number Publication Date
FR1545224A true FR1545224A (en) 1968-11-08

Family

ID=26181060

Family Applications (1)

Application Number Title Priority Date Filing Date
FR129355A Expired FR1545224A (en) 1966-12-21 1967-11-23 Process for preparing sebacic acid

Country Status (1)

Country Link
FR (1) FR1545224A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067489A2 (en) * 2003-01-23 2004-08-12 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11116739B2 (en) 2015-03-16 2021-09-14 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease
US11407705B2 (en) 2019-06-21 2022-08-09 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9000041B2 (en) 2003-01-23 2015-04-07 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7335799B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
WO2004067489A2 (en) * 2003-01-23 2004-08-12 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7335689B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US9006290B2 (en) 2003-01-23 2015-04-14 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US7405226B2 (en) 2003-01-23 2008-07-29 Pfizer Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US7576130B2 (en) 2003-01-23 2009-08-18 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US7812199B2 (en) 2003-01-23 2010-10-12 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7838554B2 (en) 2003-01-23 2010-11-23 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US8067466B2 (en) 2003-01-23 2011-11-29 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
US8153690B2 (en) 2003-01-23 2012-04-10 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
US9452964B2 (en) 2003-01-23 2016-09-27 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US8497301B2 (en) 2003-01-23 2013-07-30 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US8623915B2 (en) 2003-01-23 2014-01-07 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US7119221B2 (en) 2003-01-23 2006-10-10 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
WO2004067489A3 (en) * 2003-01-23 2004-11-25 Esperion Therapeutics Inc Hydroxyl compounds and compositions for cholesterol management and related uses
US8309604B2 (en) 2003-01-23 2012-11-13 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US9624152B2 (en) 2003-01-23 2017-04-18 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10047028B2 (en) 2003-01-23 2018-08-14 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US10118881B2 (en) 2003-01-23 2018-11-06 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10941095B2 (en) 2003-01-23 2021-03-09 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11744816B2 (en) 2015-03-13 2023-09-05 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11116739B2 (en) 2015-03-16 2021-09-14 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease
US11407705B2 (en) 2019-06-21 2022-08-09 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11613511B2 (en) 2019-06-21 2023-03-28 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11760714B2 (en) 2019-06-21 2023-09-19 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11926584B2 (en) 2019-06-21 2024-03-12 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11987548B2 (en) 2019-06-21 2024-05-21 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same

Similar Documents

Publication Publication Date Title
FR1505146A (en) Process for preparing nitrilo-tris- (methylenephosphonic acid)
CH482757A (en) Process for preparing polyamic acid
FR1545224A (en) Process for preparing sebacic acid
CH468934A (en) Process for preparing concentrated nitric acid
FR1493032A (en) Process for preparing acetic acid
FR1487936A (en) Process for preparing terephthalic acid
FR1515766A (en) Process for preparing hydroxyerephthalic acid
CH468346A (en) Process for preparing 1-amino-3-carboxy-2-propanesulfonic acid
FR1545225A (en) Process for preparing sebacic acid
FR1525523A (en) Process for preparing acetic acid
FR1449610A (en) Process for preparing deacetyl-7-aminocephalosporanic acid
FR1462796A (en) Process for preparing 4'-nitrodiphenyl-4-carboxylic acid
FR1504089A (en) Process for preparing 5-aminovaleric acid
FR1512534A (en) Process for preparing adipic acid
FR1486033A (en) Process for preparing chloropivalic acid
FR1537440A (en) Process for preparing monochloropivalic acid
FR1523584A (en) Process for preparing isomalic acid
FR1538202A (en) Process for preparing 1-amino-3-carboxy-propane-2-sulfonic acid
FR1462259A (en) Process for preparing delta3-pyrroline-2-carboxylic acid
CH434236A (en) Process for preparing 11-iodo-10-undecynoic acid
FR1375060A (en) Process for preparing alpha-amino-beta-hydroxybutyric acid
FR1475421A (en) Process for preparing pure trans-4-aminomethylcyclohexane-1-carboxylic acid
CH445479A (en) Process for preparing trans-4-aminomethyl-cyclohexane-1-carboxylic acid
FR1433279A (en) Process for preparing 5'-guanylic acid
FR1542002A (en) Process for preparing isovaleric acid